Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses (Q34386118)

1 August 2017

1 reference

title

Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses (English)

1 reference

1 August 2017

LaDu MJ

1

1 reference

1 August 2017

Shah JA

2

1 reference

1 August 2017

Reardon CA

3

1 reference

1 August 2017

Getz GS

4

1 reference

1 August 2017

Bu G

5

1 reference

1 August 2017

Hu J

6

1 reference

1 August 2017

Guo L

7

1 reference

1 August 2017

Van Eldik LJ

8

1 reference

1 August 2017

1 November 2001

1 reference

Neurochemistry International

1 August 2017

1 reference

1 August 2017

39

1 reference

1 August 2017

427-434

1 reference

1 August 2017

5-6

1 reference

Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

SP-40,40 is a constituent of Alzheimer's amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Expression and alternate splicing of apolipoprotein E receptor 2 in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E is found in astrocytes but not in microglia in the normal mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Expression of apolipoprotein E during nerve degeneration and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Lipoproteins in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E suppresses glial cell secretion of TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Characterization of apolipoprotein J-Alzheimer's A beta interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Amyloid beta-protein, APOE genotype and head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900050-X

7 January 2021

10.1016/S0197-0186(01)00050-X

Identifiers

DOI

1 reference

1 August 2017

1 reference